BNY MELLON ASSET MANAGEMENT NORTH AMERICA CORPORATION – Trademark Portfolio
Entity Type: 03
BNY MELLON ASSET MANAGEMENT NORTH AMERICA CORPORATION holds 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 36 (Insurance & Financial) — 9 filings in this category. Currently, 3 trademarks are registered. Notable registered marks include GTAA, GLOBAL TAA, and HARBORWALK. The owner is based in BOSTON, MA.
BNY MELLON CENTER
1 BOSTON PLACE
BOSTON, MA 02108
Showing of trademarks Trademarks
Trademark Classifications
BNY MELLON ASSET MANAGEMENT NORTH AMERICA CORPORATION's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Insurance; financial affairs; monetary affairs; real estate affairs
Frequently Asked Questions
How many trademarks does BNY MELLON ASSET MANAGEMENT NORTH AMERICA CORPORATION have?
BNY MELLON ASSET MANAGEMENT NORTH AMERICA CORPORATION has 9 U.S. trademarks filed with the USPTO. Of these, 3 registered, 6 cancelled.
What trademark classes does BNY MELLON ASSET MANAGEMENT NORTH AMERICA CORPORATION file in?
BNY MELLON ASSET MANAGEMENT NORTH AMERICA CORPORATION files trademarks across 1 Nice Classification class. The most active classes are Class 36 (Insurance & Financial). Class 36 covers insurance; financial affairs; monetary affairs; real estate affairs.
What are BNY MELLON ASSET MANAGEMENT NORTH AMERICA CORPORATION's most well-known trademarks?
BNY MELLON ASSET MANAGEMENT NORTH AMERICA CORPORATION's registered trademark portfolio includes well-known marks such as GTAA, GLOBAL TAA, and HARBORWALK. These are among 3 currently registered trademarks in the portfolio.
What is BNY MELLON ASSET MANAGEMENT NORTH AMERICA CORPORATION's trademark registration success rate?
BNY MELLON ASSET MANAGEMENT NORTH AMERICA CORPORATION has a 33% trademark registration rate, with 3 out of 9 resolved applications resulting in successful registration. Currently, 0 applications are pending review.